The role of endothelial cell-specific growth factors in the vascularization of the primate peri-ovulatory follicle was examined. Experiments were designed firstly to detect expression of vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) in granulosa cells and secondly, to determine whether gonadotrophins and/or steroids regulate their expression during the peri-ovulatory interval. Granulosa cells and follicular fluid were collected from rhesus macaques undergoing ovarian stimulation before (0 h), 12, or 36 h after a bolus of ovulatory human chorionic gonadotrophin (HCG), with or without steroid ablation and progestin replacement. VEGF, Ang-1 and Ang-2 mRNA were all detected prior to the ovulatory stimulus. Whereas follicular fluid VEGF concentrations increased 6-fold (P < 0.05) between 0 and 12 h, VEGF mRNA values were unchanged and were unaffected by steroid ablation. Ang-1 mRNA decreased from 0 to 12 h (P < 0.05), followed by a 30-fold increase (P < 0.05) at 36 h, while Ang-2 mRNA values were unchanged between 0, 12 and 36 h. Steroid ablation decreased (P < 0.05) Ang-1 mRNA at 36 h, and Ang-2 mRNA at 12 h, while only Ang-1 was restored by progestin replacement. These data suggest a dynamic expression of vascularspecific growth factors in a gonadotrophin-dependent, steroid-independent (VEGF) or steroid-dependent (Ang-1) manner in granulosa cells of peri-ovulatory follicles of primates.
Introduction
1 and Ang-2 mRNA in the ovary of the rat (Phillips et al., 1990; Koos, 1995; Maisonpierre et al., 1997) , as well as VEGF Recently, considerable attention has focused on endothelial mRNA in the non-human primate ovary (Ravinadranath et al., cell specific factors (Koos, 1993; Ferrara and Davis-Smyth, 1992) , suggest a role for these factors in ovarian angiogenesis. 1997) that appear to be essential for angiogenesis (Suri et al., 1996) . The mitogenic/permeability agent, vascular endothelial Notably, Maisonpierre et al. (1997) , compared the temporal growth factor (VEGF), is associated with rapid vascular growth and spatial expression patterns of Ang-1, Ang-2, and VEGF in both pathological and physiological conditions (Leung in the rat ovary, and proposed that these substances act in et al., 1989; Ferrara and Davis-Smyth, 1997) . Also, two new concert to promote or inhibit vascular restructuring. However, angiogenic factors unrelated to the heparin-binding VEGF information about tissue-and time-specific expression of these family have been recognized, angiopoietin-1 (Ang-1) and angiogenic factors during the ovarian cycle, particularly in angiopoietin-2 (Ang-2) (Davis et al., 1996; Maisonpierre et al., mono-ovular species such as primates, is lacking. 1997). Unlike VEGF, Ang-1 is unable to stimulate endothelial Recent studies also suggest that VEGF expression is regucell proliferation (Davis et al., 1996) , but instead is required lated by gonadotrophins and steroids (Ravinadranath et al., for the recruitment of peri-vascular cells that aid in the 1992; Koos, 1995; Christenson and Stouffer, 1997 ; Lee et al., maturation and stabilization of newly developed capillaries 1997; Anasti et al., 1998; Hyder et al., 1998) . VEGF mRNA (Suri et al., 1996; Hanahan, 1997; Maisonpierre et al., 1997) .
values in the rat ovary (Koos, 1995) , as well as VEGF Ang-2 is a natural antagonist for Ang-1, opposing the effect production by primate granulosa cells in vitro (Christenson of Ang-1-mediated stabilization by promoting a more plastic and Stouffer, 1997), increased after in-vivo administration of state for capillary endothelium, which can lead to endothelial a bolus of human chorionic gonadotrophin (HCG), suggesting migration and neovascularization (Maisonpierre et al., 1997) .
that VEGF expression by peri-ovulatory follicles is stimulated Although VEGF and the angiopoietins are prevalent in many by the midcycle gonadotrophin surge. Further, VEGF productissues during embryonic development, angiogenesis in the tion by T47-D breast cancer cells (Hyder et al., 1998) , and healthy adult is generally restricted to the physiological proretinal pigment epithelial cells (Sone et al., 1996) increased cesses of follicular development, corpus luteum formation, after incubation in the presence of progesterone. However, and uterine endometrial proliferation during the ovarian cycle detailed studies investigating the regulation of VEGF or the (Findlay, 1986; Reynolds et al., 1992; Augustin et al., 1995) . Previous studies demonstrating the expression of VEGF, Angangiopoietins by the gonadotrophin surge or steroids during point) received TRL plus the non-metabolizable progestin R5020 The specific objectives of this study were: (i) to determine necessary to reinstate the ovulatory process (Hibbert et al., 1996 (Wolf et al., 1990) . After the oocytes were removed for ovarian stimulation before (0 h), 12, or 36 h after administration other studies (Lanzendorf et al., 1990) , somatic cells were harvested of an ovulatory HCG bolus. This model provides multiple prefrom follicular aspirates by centrifugation at 277 g for 15 min at 4°C. The resulting follicular fluid was divided into aliquots of 25-100 µl ovulatory follicles that are capable of ovulating (Hibbert et al., and stored at -80°C. The cell pellet was resuspended in Tyrode's 1996), and are steroidogenically similar to those of natural albumin lactate pyruvate medium (TALP)-HEPES (Bavister et al., cycles 
Materials and methods
F-10, cell numbers were determined using a haemacytometer, and cell viability was assessed by Trypan Blue exclusion. Animals
The general care and housing of rhesus monkeys at the Oregon VEGF assay Regional Primate Research Center (ORPRC) was described previously Follicular fluid VEGF concentrations were determined by enzyme- (Wolf et al., 1990) . Animal protocols and experiments were approved linked immunosorbent assay (ELISA) (Quantikine Human VEGF by the ORPRC Animal Care and Use Committee, and studies were Immunoassay; R&D Systems Inc, Minneapolis, MN, USA). This conducted in accordance with the NIH guide for the care and use of highly specific sandwich assay displays no cross-reactivity with Ͼ90 laboratory animals. Adult female rhesus monkeys exhibiting normal cytokines tested (R&D Systems), and was validated for macaque menstrual cycles of~28 days were stimulated with recombinant studies using serum (Christensen and Stouffer, 1997). The lower limit human gonadotrophins, i.e. recombinant human follicle stimulating of detectability was 30 pg/ml. Pooled samples of human follicular hormone (rhFSH), 30 IU i.m. twice daily for 8 days; and recombinant fluid were used in a single assay to determine the intra-assay human luteinizing hormone (rhLH), 30 IU twice daily on days 7 and coefficient of variation (typically Ͻ5%). 8 (Laboratoires Serono SA, Aubonne, Switzerland) beginning 1-3 days after the onset of menses in order to promote the development Total RNA isolation and reverse transcription-polymerase of multiple pre-ovulatory follicles (VandeVoort et al., 1989) . Monkeys chain reaction (RT-PCR) also received a daily s.c. injection of the gonadotrophin-releasing hormone (GnRH) antagonist Antide [08:00, 0.5 mg/kg body weight Total RNA was isolated from 10 4-10 5 granulosa cells using the Trizol reagent (BRL, Gaithersburg, MD, USA) as per manufacturers in propylene glycol:water (1:1); Laboratoires Serono SA, Aubonne, Switzerland] throughout the stimulation protocol to prevent an endoinstructions. Quality and quantity of RNA was determined by electrophoresis of samples against known concentrations of total ovarian genous LH surge. This or comparable protocols using urinary gonadotrophin preparations were previously utilized to study folliculogenesis RNA in a 2% agarose gel stained with ethidium bromide. RNA samples were all reverse transcribed and subjected to PCR as and peri-ovulatory events in the primate, including the effects of steroid deprivation (Hibbert et al., 1996, Chaffin and .
previously described . Briefly, granulosa cell RNA (0.5-1.0 µg in 10 µl) was treated with RNase-free DNase Animals were assigned randomly to receive no ovulatory stimulus, or a standard ovulatory stimulus of 1000 IU rHCG (single injection I (BRL) to remove contaminating genomic DNA, before reverse transcription using 200 IU of Molony murine leukaemia virus reverse i.m.; Laboratoires Serono SA) to initiate peri-ovulatory events (VanderVoort et al., 1989; Zelinski et al., 1995 Zelinski et al., , 1997 . Pre-ovulatory transcriptase (MMLV; BRL). PCR was performed in a 75 µl volume containing experimental ϩ internal standard primers of which the follicles (ജ4 mm) were aspirated using a 22 gauge needle during laparotomy of anaesthetized animals either the morning after the last concentrations were determined as part of the validation process with appropriate buffers (7.5 µl of 10ϫ Taq buffer, 2 mmol/l MgCl 2 , 2 µl LH/FSH treatment (0 h) or 12, or 36 h following administration of 1000 IU rHCG (n ϭ 3-5 monkeys/time point). An additional group of 10 mmol/l dNTPs and 3 IU of Taq DNA polymerase; Promega Biotech, Madison, WI, USA). Each reaction was overlayed with 40 µl of monkeys (n ϭ 3/time point) was stimulated in an identical fashion, but also received the 3β-HSD inhibitor Trilostane (TRL; Sanofi of mineral oil, and placed in a thermal cycler (MJ Research, Watertown, MA, USA) for an empirically determined number of Research Division, Malvern, PA, USA), given orally as 1 g in 8 ml orange Kool-Aid (Kraft General Foods, Inc., White Plains, NY, USA) cycles of denaturing at 94°C for 30 s, annealing at 60°C for 1 min and primer extension at 72°C for 1 min. Aliquots of each PCR containing 1% (w/v) gum tragacanth (Sigma). TRL was administered 4 h prior to HCG administration and every 12 h thereafter until the reaction (20 µl) were electrophoresed through a 2% agarose gel stained with 0.1 µg/ml ethidium bromide. Gels were visualized on a time of follicular aspiration to suppress endogenous steroid production , which ultimately inhibits ovulation UV transilluminator and photographed using 667 Polaroid film, and the photographs were analysed by densitometry. All values were (Hibbert et al., 1996) . A third group of animals (n ϭ 3/time normalized to the internal standard cyclophilin; no apparent changes were observed in granulosa cell expression for the standard between time-points following administration of HCG.
Validation of the RT-PCR assay was performed (see Ma et al., 1994) using granulosa cells aspirated 27 h following HCG during routine in-vitro fertilization (IVF) protocols as a source of RNA (data not shown). Briefly, the amount of co-amplified product for experimental and internal standard primer sets was linear and parallel with increasing amounts of cDNA and both sets of primers were in the exponentially increasing phase relative to the number of cycles. In order to control for between assay variability, total RNA from granulosa cells of three monkeys was combined and reverse transcribed as described to form a pool that was amplified as four or five replicates during each PCR with the appropriate set of primers. Intraassay variability, calculated using the four or five replicate pool samples, typically ranged from Ͻ1 to 12%. Because data for each Figure 1 . Changes in vascular endothelial growth factor (VEGF) set of primers was collected in two rounds of PCR reactions, the protein concentrations in follicular fluid aspirated either before (0) pool replicates were also used to normalize data between reactions.
or 12 or 36 h after administration of an ovulatory bolus of human Sequence analysis (performed by ORPRC Molecular Biology Core) chorionic gonadotrophin (HCG) Ϯ steroid depletion. Control (HCG alone, n ϭ 3); trilostane (TRL; n ϭ 3). Letters above bars denote confirmed the identity of the cDNA fragments. Homology of the significant differences (P Ͻ 0.05) across time. cDNA fragments to the published sequences of corresponding cDNAs from other species was determined using DNASTAR software (Madison, WI, USA).
concentrations remained elevated at 36 h, but values were intermediate between 0 and 12 h values. Treatment with TRL Oligonucleotide PCR primers did not alter concentrations of VEGF at either 12 or 36 h after Oligonucleotides used for PCR were synthesized by Gibco-BRL HCG administration. Since there was no effect of the 3β-HSD Custom Primers. Table I TRL, or TRLϩR5020-treated animals was also analysed at 0, 12, and 36 h after HCG administration (Figure 3) . Ang-1 mRNA
Results
values were detectable in controls at time 0. Gonadotrophin exposure initially decreased Ang-1 mRNA expression between VEGF concentrations in follicular fluid from control or TRLtreated animals at 0, 12, and 36 h after HCG administration 0 and 12 h (P Ͻ 0.05), followed by a 30-fold increase (P Ͻ 0.05) by 36 h after HCG. Treatment with TRL or TRLϩR5020 are depicted in Figure 1 . Appreciable amounts of VEGF were detectable at time 0. Control (HCG alone) animals displayed had no effect on the decline in Ang-1 mRNA expression at 12 h after HCG. However, the elevated Ang-1 expression at a 6-fold increase (P Ͻ 0.05) in follicular fluid VEGF concentrations within 12 h after receiving a standard gonadotrophin 36 h was markedly decreased (P Ͻ 0.05) by TRL treatment, and partially restored to control levels by R5020. bolus (1000 IU HCG) to initiate peri-ovulatory events. VEGF pre-ovulatory stage, but intense staining in the newly-formed To determine the similarity of the Ang-1 and Ang-2 products corpus luteum (Kamat et al., 1995; Gordon et al., 1996) . of the monkey to the corresponding section of the human Collectively, the data support the concept that the midcycle sequence, the granulosa cell RT-PCR product was cloned into gonadotrophin surge promotes the production of the angiogenic pGEM-T and sequenced. There was 96.1% homology between factor VEGF by luteinizing granulosa cells in the primate perithe nucleotide sequence for the monkey Ang-1 cDNA and that ovulatory follicle. of the corresponding region of the hAng-1 cDNA, while Unlike VEGF secretion, VEGF mRNA expression was not monkey Ang-2 was 96.5% homologous with the hAng-2 cDNA altered by the gonadotrophin surge during the 36 h peri-(sequence data not shown).
ovulatory interval. Interestingly, HCG stimulated expression of VEGF mRNA in human luteinized granulosa cells during Discussion 10 days of culture (Neulen et al., 1998) . In addition, VEGF mRNA values in granulosa cells increased 10 h after HCG This study is the first to demonstrate gonadotrophin regulation of VEGF secretion in vivo in the pre-ovulatory follicle of the administration in the rat (Koos, 1995) . These discrepancies may be time-and species-dependent. Alternatively, differences primate ovary. Follicular fluid VEGF concentrations increased 6-fold by 12 h after the administration of an ovulatory stimulus in the primers utilized for PCR in these studies may be relevant. While the rat study utilized a primer set that resulted of HCG, and remained elevated at 36 h. These data are inhibitor (TIMP-1) , the current data from TRL-treated animals supports the concept that VEGF mRNA and protein production is steroid-independent. Similarly, Lee et al. (1997) reported that in-vitro incubation of human luteinized granulosa cells with Trilostane or Trilostane plus the progesterone receptor antagonist ZK137.316 did not alter VEGF production. Whether LH action to promote VEGF production is a direct effect, mediated by non-steroidal local factors, or modulated by other changes in the follicular milieu, such as hypoxia (Friedman et al., 1997) , awaits further study. This is the first report detecting Ang-1 and Ang-2 in the primate ovary, notably in granulosa cells during the periovulatory interval. Patterns of Ang-1 and Ang-2 expression differed during the peri-ovulatory interval; Ang-2 expression remained at a constant level, whereas Ang-1 expression initially declined 12 h after the gonadotrophin surge with a subsequent dramatic increase close to the time of ovulation. The constant expression of Ang-2 in the face of decreasing Ang-1 expression 12 h after HCG, may represent the initiation of events that lead to increased plasticity or loosening of the capillary support matrix associated with angiogenesis (Hanahan, 1997). The subsequent robust increase in Ang-1 expression around ovulation, suggests that a concomitant increase in Ang-1 protein ( Maisonpierre et al., 1997) . Therefore, expression of angiogenic factors in theca, as well as the granulosa, cells may regulate and fine-tune the formation and establishment of capillaries in multiple-sized products (Koos, 1995) , our study utilized a primer set that encompassed all five VEGF isoforms. Although into the avascular tissue. Further studies addressing VEGF, Ang-1 and Ang-2 mRNA and protein expression patterns in VEGF 165 is generally the most abundant isoform (Houck et al., 1991; Ferrara and Davis-Smyth, 1997; Soker et al., 1997) , all compartments of the primate pre-ovulatory follicle are warranted. the relative expression of VEGF 121 , VEGF 145 , VEGF 189 and VEGF 206 may depend on the cell line or library screened Gonadotrophin and steroid regulation of Ang-1 and Ang-2 mRNA expression during the peri-ovulatory interval is dis- (Houck et al., 1991) . The possibility that cellular expression of VEGF isoforms changes during the peri-ovulatory interval, tinctly different immediately following the surge (ഛ 12 h) compared to just prior to follicle rupture (ജ 36 h). First, Angperhaps to equilibrate total VEGF expression, cannot be ruled out. Nevertheless, the increase in follicular fluid VEGF 1 expression decreases 10-fold in primate granulosa cells 12 h after the administration of HCG. Interestingly, the decline in secretion during the peri-ovulatory interval without an apparent increase in cellular VEGF mRNA suggests a post-transcripAng-1 expression coincides with an increase in progesterone and VEGF concentrations in the follicular fluid. If progesterone tional site of regulation of VEGF production by gonadotrophins.
was responsible for down-regulating Ang-1, a progestin synthesis inhibitor should restore Ang-1 expression to control Although gonadotrophins clearly promote VEGF production by granulosa cells in the ovulatory follicle, other factors values. However, treatment with Trilostane did not alter Ang-1 expression 12 h after HCG. Thus, the initial reduction in may mediate this effect or operate concomitantly to regulate production. Serum progesterone concentrations also increase Ang-1 expression in the peri-ovulatory follicle may be directly regulated by gonadotrophins secreted around the time of during the peri-ovulatory interval and are essential for LHinduced ovulation and luteinization in primates (Hibbert et al., ovulation. Conversely, Ang-2 expression was not altered by HCG administration, and appears to be continually expressed 1996). A correlation between VEGF and progesterone concentrations in follicular fluid and in media from granulosa cell in the maturing follicle during the peri-ovulatory interval. Unlike Ang-1, Ang-2 is steroid-regulated early in the pericultures has been established in primates (Christensen and Stouffer, 1997; Lee et al., 1997; Anasti et al., 1998 , operate alone or synergistically Friedman, C.I., Danforth, D.R., Herbosa-Encarnacion, C. et al. (1997) with progesterone to modulate angiopoietin mRNA or protein 
